FindTrial
Sign In

Effect of Continuous Intra Arterial Weak Bicarbonate Infusion on the Use of Fluid and Bicarbonate Boluses to Correct Metabolic Acidosis in Babies Weighing Less than 1000 g and Who are Less than 32 Weeks Gestation at Birth

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN22535466
Enrollment
Unknown
Registered
2004-09-30
Start date
2001-10-30
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal Diseases: Metabolic acidosis Neonatal Diseases Other transitory neonatal electrolyte and metabolic disturbances

Interventions

Randomised controlled trial

Sponsors

Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Babies 32 weeks gestational age weighing <1000 g

Exclusion criteria

Exclusion criteria: Does not meet inclusion criteria

Design outcomes

Primary

MeasureTime frame
Continuous weak alkali infusion may prevent acidosis from occurring and reduce the need for boluses of fluid or bicarbonate.—

Secondary

MeasureTime frame
Not provided at time of registration—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026